- Before coming to GSK, Urbain Bruyere spent his career in high-hazard industries. Urbain joined the BP corporate Environment Health and Safety team five months before the 2005 Texas City explosion and was still with the team during the 2010 Deepwater Horizon explosion. In 2015, Urbain joined Anglo American, one of the world’s largest mining companies which was then experiencing 11 fatalities a year.
- In September 2017, Urbain was recruited by GSK to lead EHS at its 70 manufacturing sites. At that time, the main safety KPI tracked at the executive level was the reportable incidents and illnesses rate, and the organisation was very focused on zero accidents. He was hired to bring high-hazard industry practices and safety differently thinking (human and organisational factors) into pharma.
- Now, the safety conversations have shifted, and GSK is focused on getting deeper lessons from high-potential severity incidents, improving operational risk management, strengthening accountability for high-severity risks and measuring associated high-severity risk management maturity. GSK targets not only reducing safety accidents but also and primarily increasing safety defences. The focus is to make sure that things go right rather than to prevent things from going wrong.
Dr Urbain Bruyere, Vice President EHS Pharma Supply Chain, GSK